An outbreak of the Marburg virus disease (MVD), also known as the “bleeding eye virus,” has killed at least 15 people in Rwanda. As of November 29, the virus has also infected 66 others, according to the Ministry of Health. The rapid spread of the virus has raised alarms, with concerns growing as it spreads to more countries.
The Growing Threat of Marburg Virus
The Marburg virus is highly contagious and causes severe symptoms, often leading to death. The outbreak in Rwanda has caused widespread fear, as more cases are reported. Health officials are closely monitoring the situation as the virus continues to spread.
Warnings Issued for Marburg Virus in 17 Countries
Warnings are issued for this virus in 17 countries. Travelers are being warned about the Marburg virus, also called the “bleeding eye virus” because of one of its symptoms. Along with mpox and Oropouche fever, Marburg virus is another threat to travelers this holiday season.
What Is the Marburg Virus?
Marburg is part of the Ebola family. It causes viral hemorrhagic fever, which damages blood vessels and causes severe bleeding. The virus spreads from fruit bats to humans through contact with infected bodily fluids, such as blood, saliva, or urine.
Symptoms of Marburg Virus
Marburg virus symptoms are similar to Ebola. Infected people have a high fever, headaches, muscle pain, sore throat, vomiting, rash, and diarrhea. In severe cases, the virus can cause internal bleeding, organ failure, and shock, leading to death. In fatal cases, people may experience weight loss, bleeding from the nose, eyes, mouth, or vagina, and confusion.
The World Health Organization (WHO) describes patients in severe stages as “ghost-like,” with deep-set eyes, an expressionless face, and extreme lethargy.
Treatment and Mortality Rate
The death rate of the Marburg virus varies between 24% and 88%, depending on medical care. There is no specific antiviral treatment. However, rehydration and symptom management can help. Researchers are studying experimental vaccines, as well as blood products, immune therapies, and drug treatments.
